SOP Guide for Pharma

SOP for Incorporating Anti-Inflammatory Agents in Nasal Sprays




SOP for Incorporating Anti-Inflammatory Agents in Nasal Sprays



Standard Operating Procedure for Incorporating Anti-Inflammatory Agents in Nasal Sprays

1) Purpose

The purpose of this SOP is to outline the process for incorporating anti-inflammatory agents into nasal spray formulations to ensure consistent dosage and therapeutic efficacy.

2) Scope

This SOP applies to all personnel involved in the formulation of nasal sprays containing anti-inflammatory agents at [Company Name].

3) Responsibilities

  • Operators: Responsible for incorporating anti-inflammatory agents into the formulation and ensuring even distribution.
  • QA: Verifies the concentration of anti-inflammatory agents and checks for uniformity in the formulation.

4) Procedure

4.1 Selection of Anti-Inflammatory Agents

4.1.1 Types of Anti-Inflammatory Agents

  • Select appropriate anti-inflammatory agents based on the therapeutic requirements of the formulation (e.g., corticosteroids, NSAIDs).

4.1.2 Weighing of Agents

  • Weigh the required amount of anti-inflammatory agents according to the formulation specifications.
  • Document all weights in the batch manufacturing record (BMR).

4.2 Incorporation of Anti-Inflammatory Agents

4.2.1 Mixing

  • Mix the anti-inflammatory agent into the nasal spray solution under constant stirring to ensure uniform distribution.

4.2.2 Homogenization

  • Use a homogenizer if required to ensure even distribution of the active agent in the formulation.

4.3 Testing

4.3.1 Assay Testing

  • Test the formulation to verify
that the concentration of the anti-inflammatory agent meets the specified range.

4.3.2 pH and Osmolality Testing

  • Test the pH and osmolality of the formulation to ensure it falls within the required range for nasal sprays.

4.4 Filtration and Filling

4.4.1 Filtration

  • Filter the formulation through a 0.22-micron filter to ensure sterility.

4.4.2 Filling

  • Fill the sterile solution into nasal spray containers using aseptic techniques.

4.5 Documentation

  • Document all steps, including the amount of anti-inflammatory agent used, assay results, and pH and osmolality values in the batch manufacturing record (BMR).

5) Abbreviations, if any

  • NSAIDs: Non-Steroidal Anti-Inflammatory Drugs
  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record

6) Documents, if any

  • Batch Manufacturing Record (BMR)
  • pH and Osmolality Log

7) References, if any

  • USP 39 – Anti-Inflammatory Drugs in Nasal Sprays

8) SOP Version

Version 1.0

Annexure

pH and Osmolality Log Template

Date Formulation pH Osmolality (mOsm/kg) Operator Initials QA Approval
DD/MM/YYYY Formulation Name pH Value Osmolality Operator Name QA Name
           


Exit mobile version